As GLP-1 adoption grows and new applications for the drugs come to light, experts say that could have sweeping impacts for ...

Pfizer has urged a Florida federal judge to dismiss lawsuits claiming its birth control shot Depo-Provera can cause users to ...

In patients with active lupus nephritis, iscalimab shows efficacy in reducing proteinuria and is generally well tolerated.

Adults with vitiligo show a higher prevalence of thyroid disease, alopecia areata, rheumatoid arthritis, and type 1 diabetes, ...

Pfizer stock is undervalued with strong non-COVID growth, robust Q2 2025 results, and strategic R&D pivots. See more on PFE ...

In Q2 2025, Pfizer reported notable revenues from key oncology drugs: The increasing demand for drugs like Padcev and the introduction of new therapies such as Elrexfio, which generated $85 million in ...

Despite the positive outlook, Pfizer still faces substantive execution risks. The looming challenge of losing exclusivity on certain drugs could impact revenue streams significantly. Moreover, while ...

The Washington State Employment Security Department has said that 100 workers are affected by Pfizer’s (NYSE:PFE) layoff, ...

A close associate of the HHS secretary claims the U.S. government will soon pull COVID-19 mRNA jabs from the market.

Despite saving millions of lives during the pandemic, the Trump administration is planning to nix nationwide access to the ...

Companies have claimed improvements to yield, batch consistency and output while acknowledging the risks and challenges ...

Even as Indian equities tripled investor wealth post-pandemic, several marquee stocks—from paints to pharma and banks—are ...